AntiCan Cancer Research Results
AntiCan, Anticancer Effect: Click to Expand ⟱
| Source: |
| Type: general indicator |
Anticancer Effect
|
GC, Gastric Adenocarcinoma: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
AntiCan↑, Apoptosis↑, eff↑,
Apoptosis↑, TumCP↓, MAPK↓, PI3K↓, Akt↓, NF-kB↓, AntiCan↑, ChemoSen↑, TumCCA↑, Apoptosis↑, BioAv↑, selectivity↑, TGF-β↓, ROS↑, DNAdam↑, p‑P53↑, P21↑, cycD1/CCND1↓, cycE/CCNE↓, CDK4↓, CDK6↓, MMP↓, NF-kB↑, BAX↑, Bcl-2↓, ER Stress↑, Casp↑, AIF↑, Fas↑, Casp8↑, Cyt‑c↑, cl‑PARP↑, Ca+2↑, *NRF2↑, *chemoP↑, *GutMicro↑, CycB/CCNB1↑, H2S↑, HIF-1↓, RadioS↑,
AntiCan↑, ChemoSen↑, angioG↓, chemoP↑, *GutMicro↑, *antiOx↑, other↝, GSH↓, Thiols↓, *ROS↓, *hepatoP↑, *Inflam↓, *NF-kB↓,
AntiCan↑, Apoptosis↑, TumCP↓, TumMeta↓, BAX↑, TumAuto↑, ROS↑, NRF2↝, PI3K↓, Akt↓, NF-kB↓, TGF-β↓, SMAD4↓, GPx4↓, MMP↓, *HO-1↑, *GSTs↑, *antiOx↑, *AntiTum↑, *NRF2↑, ChemoSen↑, Akt↓, mTOR↓, FAK↓, Ki-67↓,
chemoPv↑, AntiCan↑, *antiOx↑, *Inflam↓, miR-21↓, miR-34a↑, miR-200b↑, miR-27a-3p↓,
*AntiCan↑, *ROS↓, *GSH↑, *GPx↑, *GSTs↑, TumCG↓, Apoptosis↑, ERK↓, Bcl-2↓, BAX↑, Cyt‑c↑, TumCCA↑, *DNAdam↓,
antiOx↑, AntiCan↑, ROS↓, JAK1↓, STAT3↓, Wnt↓, β-catenin/ZEB1↓, cMyc↓, cycE/CCNE↓, TumCP↓, Risk↓,
AntiCan↑, DNAdam↑, Apoptosis↑, TumCCA↑, Bax:Bcl2↑, MMP↓, Casp3↑, PI3K↓, Akt↓,
Showing Research Papers: 1 to 8 of 8
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 8
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
antiOx↑, 1, GPx4↓, 1, GSH↓, 1, NRF2↝, 1, ROS↓, 1, ROS↑, 2, Thiols↓, 1,
Mitochondria & Bioenergetics ⓘ
AIF↑, 1, MMP↓, 3,
Core Metabolism/Glycolysis ⓘ
cMyc↓, 1, H2S↑, 1,
Cell Death ⓘ
Akt↓, 4, Apoptosis↑, 6, BAX↑, 3, Bax:Bcl2↑, 1, Bcl-2↓, 2, Casp↑, 1, Casp3↑, 1, Casp8↑, 1, Cyt‑c↑, 2, Fas↑, 1, MAPK↓, 1,
Transcription & Epigenetics ⓘ
miR-21↓, 1, miR-27a-3p↓, 1, other↝, 1,
Protein Folding & ER Stress ⓘ
ER Stress↑, 1,
Autophagy & Lysosomes ⓘ
TumAuto↑, 1,
DNA Damage & Repair ⓘ
DNAdam↑, 2, p‑P53↑, 1, cl‑PARP↑, 1,
Cell Cycle & Senescence ⓘ
CDK4↓, 1, CycB/CCNB1↑, 1, cycD1/CCND1↓, 1, cycE/CCNE↓, 2, P21↑, 1, TumCCA↑, 3,
Proliferation, Differentiation & Cell State ⓘ
ERK↓, 1, miR-34a↑, 1, mTOR↓, 1, PI3K↓, 3, STAT3↓, 1, TumCG↓, 1, Wnt↓, 1,
Migration ⓘ
Ca+2↑, 1, FAK↓, 1, Ki-67↓, 1, miR-200b↑, 1, SMAD4↓, 1, TGF-β↓, 2, TumCP↓, 3, TumMeta↓, 1, β-catenin/ZEB1↓, 1,
Angiogenesis & Vasculature ⓘ
angioG↓, 1, HIF-1↓, 1,
Immune & Inflammatory Signaling ⓘ
JAK1↓, 1, NF-kB↓, 2, NF-kB↑, 1,
Hormonal & Nuclear Receptors ⓘ
CDK6↓, 1,
Drug Metabolism & Resistance ⓘ
BioAv↑, 1, ChemoSen↑, 3, eff↑, 1, RadioS↑, 1, selectivity↑, 1,
Clinical Biomarkers ⓘ
Ki-67↓, 1,
Functional Outcomes ⓘ
AntiCan↑, 7, chemoP↑, 1, chemoPv↑, 1, Risk↓, 1,
Total Targets: 68
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress ⓘ
antiOx↑, 3, GPx↑, 1, GSH↑, 1, GSTs↑, 2, HO-1↑, 1, NRF2↑, 2, ROS↓, 2,
DNA Damage & Repair ⓘ
DNAdam↓, 1,
Immune & Inflammatory Signaling ⓘ
Inflam↓, 2, NF-kB↓, 1,
Clinical Biomarkers ⓘ
GutMicro↑, 2,
Functional Outcomes ⓘ
AntiCan↑, 1, AntiTum↑, 1, chemoP↑, 1, hepatoP↑, 1,
Total Targets: 15
Scientific Paper Hit Count for: AntiCan, Anticancer Effect
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:28 Cells:% prod#:% Target#:813 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid
Home Page